In addition, 17 further ARHGAP26/anti-Ca-positive patients were reported by the Mayo Clinic in 2020, 15 of whom had subacute progressive cerebellar ataxia and 2 peripheral neuropathy [15], and several as yet unpublished additional cases were identified in our laboratories over the subsequent years. Here, ARHGAP26 is linked to peripheral neuropathy.